Organisation paid for research Program year 2025 Source: CMS Open Payments

El Paso Eye Surgeons PA

Neither a doctor nor a teaching hospital

Research payments

$1,584,390

1,914 payments

Through program year 2025, El Paso Eye Surgeons PA is reported as receiving $1,584,390 in research payments, across 1,914 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$286,054	130
2024	Research	$324,429	223
2023	Research	$234,564	89
2022	Research	$151,460	351
2021	Research	$491,909	990
2020	Research	$21,555	36
2019	Research	$74,419	95

Breakdown

Who paid Research payments · program years 2019–2025

Alcon Research LLC $967,782 1,852 payments
AbbVie, Inc. $481,141 47 payments
Ivantis, Inc $85,953 9 payments
Sight Sciences, Inc. $42,535 4 payments
Allergan Inc. $6,980 2 payments

Studies the money was for Research payments · program years 2019–2025

Post Approval Study of the AcrySof IQ ReSTOR Toric IOL $546,030 1,329 payments
The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial $339,198 395 payments
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma $280,356 33 payments
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma $151,073 5 payments
CS Summit $70,745 3 payments
Post Approval Study of the AcrySof IQ ReSTOR Toric IOL (Models SND1T3-T6) $63,114 91 payments
An observational multicenter clinical study to assess the long-term safety and effectiveness of the OMNI Surgical System in combination with cataract surgery in eyes with open angle glaucoma (GEMINI 2.0) $33,917 2 payments
Post Approval Study of the AcrySof IQ ReSTOR Toric IOLs $19,440 37 payments
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma $17,126 1 payment
Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial (SUMMIT) $11,305 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.